CytoDyn Inc. Uncategorized Contracts & Agreements
23 Contracts & Agreements
- Second Amendment dated December 1, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on December 7, 2022)
- Amendment dated July 18, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on July 25, 2022)
- Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on April 11, 2022)
- Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (the Company agrees to furnish a copy of Schedule 3, which has been... (Filed With SEC on February 17, 2022)
- Placement Agent Agreement (Filed With SEC on August 29, 2019)
- Product Specific Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019 (Filed With SEC on August 14, 2019)
- Form of Exercise Agreement (Filed With SEC on May 9, 2019)
- Placement Agent Agreement (Filed With SEC on April 5, 2019)
- Placement Agent Agreement (Filed With SEC on January 31, 2019)
- Placement Agent Agreement (Filed With SEC on May 22, 2018)
- Form of Amendment to Placement Agent Warrants (Filed With SEC on April 9, 2018)
- Form of Placement Agent Agreement (Filed With SEC on January 23, 2018)
- Form of Placement Agent Agreement (Filed With SEC on September 8, 2017)
- CYTODYN INC. 2012 EQUITYINCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on July 20, 2017)
- WORK STATEMENT NO. 01 (Filed With SEC on April 13, 2017)
- FIRST AMENDMENT TO PLACEMENTAGENT AGREEMENT January 30, 2017 (Filed With SEC on January 31, 2017)
- PLACEMENT AGENT AGREEMENT January 11, 2017 (Filed With SEC on January 31, 2017)
- Alpha Venture Capital Management, LLC Post Office Box 2477 Lakeland,Florida, 33806, USA September 25, 2014 (Filed With SEC on October 10, 2014)
- CYTODYN INC. CONSULTINGAGREEMENT (Filed With SEC on July 10, 2014)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on April 11, 2014)
- AMENDMENT NUMBER FIVE TO CLINICAL TRIAL AGREEMENT (Filed With SEC on November 3, 2011)
- AMENDMENT NUMBER FOUR TO CLINICAL TRIAL AGREEMENT (Filed With SEC on October 7, 2011)
- AMENDMENT NUMBER FIVE TO CLINICAL TRIAL AGREEMENT (Filed With SEC on May 24, 2011)
